Shifting T-cell activation thresholds in autoimmunity and determinant spreading

Immunological Reviews

Volumn 164, Issue , 1998, Pages 53-61

  Lehmann, Paul V ^a   Targoni, Oleg S ^a   Forsthuber, Thomas G ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; EFFECTOR CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENE;

ANIMALS; AUTOIMMUNITY; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MYELIN BASIC PROTEINS; T-LYMPHOCYTES;

EID: 0031756746     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01207.x     Document Type: Article

References (59)

1. Burnet FM, Fenner F. The production of antibodies. Melbourne: Macmillian; 1949. p.102-105.
2. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, von Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 1988;333:742-746.
3. Ashton-Rickardt PG, et al. Evidence for a differential avidity model of T cell selection in the thymus. Cell 1994;76:651-663.
4. Ashton-Rickardt PG, Tonegawa S. A differential-avidity model for T-cell selection. Immunol Today 1994;8:362-366.
5. Zamvil SS, Mitchell DJ, Moore AC, Kitamura K, Steinman L, Rothbard JB. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 1986;324:258-260.
6. Goverman J, Woods A, Larson L, Weiner L, Hood L, Zaller DM. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993;72:551-560.
7. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994;78:399-408.
8. Liu GY, Fairchild PJ, Smith RM, Prowle JR, Kioussis D, Wraith DC. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 1995;3:407-415.
9. Mathisen PM, Pease S, Garvey J, Hood L, Readhead C. Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo. Proc Natl Acad Sci USA 1993;90:10125-10129.
10. Pribyl TM, et al. The human myelin basic protein gene is included within a 179-kilobase transcription unit: expression in the immune and central nervous system. Proc Natl Acad Sci USA 1993;90:10695-10699.
11. Fritz RB, Zhao ML. Thymic expression of myelin basic protein (MBP). Activation of MBP-specific T cells by thymic cells in the absence of exogenous MBP. J Immunol 1996;157:5249-5253.
12. Fairchild PJ, Wildgoose R, Atherton E, Webb S, Wraith DC. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int Immunol 1993;5:1151-1158.
13. Janeway CA Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992;13:11-16.
14. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
15. Fearon DT. Seeking wisdom in innate immunity. Nature 1997;388:323-324.
16. Harrington CJ, et al. Differential tolerance in induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity 1998;8:571-580.
17. Targoni OS, Lehmann PV. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J Exp Med 1998;187:2055-2065.
18. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-157.
19. Ignatowicz L, et al. T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity 1997;7:179-186.
20. 0/0 mice. Immunity 1997;7:187-195.
21. Forsthuber T, Yip HC, Lehmann PV. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996;271:1728-1730.
22. Swierkosz JE, Swanborg RH. Immunoregulation of experimental allergic encephalomyelitis: conditions for induction of suppressor cells and analysis of mechanism. J Immunol 1977;4:1501-1506.
23. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligonucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med. 1997;186:1623-1631.
24. Hood L, et al. Autoimmune disease and T-cell immunologic recognition. Cold Spring Harb Symp Quant Biol 1989;54:859-874.
25. Mor F, Cohen IR. Pathogenicity of T cells responsive to diverse cryptic epitopes of myelin basic protein in the Lewis rat. J Immunol 1995;155:3693-3699.
26. + T cells are hyperreactive to antigenic challenge in vitro. J Exp Med 1996;184:2141-2151.
27. Cai Z, Brunmark A, Jackson M, Loh D, Peterson P, Sprent J. Transfected Drosophila cells as a probe for defining the minimal requirements for stimulating unprimed CD8+ T cells. Proc Natl Acad Sci USA 1996;93:14736-14741.
28. Dubey C, Croft M, Swain SL. Costimulatory requirements of naive CD4+ T cells. J Immunol 1995;155:45-57.
29. Bachman MF, et al. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 1997;7:549-557.
30. Gapin L, de Alba YB, Casrouge A, Cabaniols JP, Kourilsky P, Kanellopoulos J. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model. J Immunol 1998;160:1555-1564.
31. Butz EA, Bevan MJ. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells. J Immunol 1998;160:2139-2144.
32. Levin D, Constant S, Pasqualini T, Flavell R, Bottomly K. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo. J Immunol 1993;151:6742-6750.
33. Moreno J, Vignali DA, Nadimi F, Fuchs S, Adorini L, Hammerling GJ. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from these derived from exogenous antigen. J Immunol 1991;147:3306-3313.
34. Sun D. Major role of antigen-presenting cells in the response of rat encephalitogenic T cells to myelin basic proteins. J Immunol 1993;151:111-118.
35. Sun D, Hu X-S, Coleclough C. The clonal composition of myelin basic protein-reactive encephalitogenic T cell populations is influenced both by the structure of relevant antigens and the nature of antigen-presenting cells. Eur J Immunol 1995;25:69-74.
36. d-restricted hen egg lysozyme determinant. Eur J Immunol 1996;26:1656-1659.
37. Perry LL, Barzaga ME. Kinetics and specificity of B- and T-cell responses in relapsing experimental allergic encephalomyelitis. J Immunol 1987;138:1434-1441.
38. McCarron RM, Fallisand RJ, McFarlin DE. Alterations in T-cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J Neuroimmunol 1990;29:73-79.
39. Mamula MJ, Lin R-H, Janeway CA Jr, Hardin JA. Breaking T cell tolerance with foreign and self co-immunogens. J Immunol 1992;149:789-795.
40. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995;182:75-85.
41. Perry LL, Barzaga-Gilbert, Trotter JL. T-cell sensitization to proteolipid protein in myelin basic protein-induced experimental allergic encephalomyelitis. J Neuroimmunol 1991;33:7-15.
42. Kaufman DL, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993;366:69-72.
43. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993;366:72-75.
44. Cross AH, Tuohy VK, Raine CS. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell Immunol 1993;146:261-269.
45. Miller SD. et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997;3:1133-1136.
46. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993;14:203-208.
47. Sercarz E, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993;11:729-766.
48. Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med 1995;181:1945-1948.
49. Vanderlugt CJ, Miller SD. Epitope spreading. Curr Opin Immunol 1996;8:831-836.
50. Tian J, Lehmann PV, Kaufman DL. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J Exp Med 1997;186:2039-2043.
51. Kennedy MK, et al. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. J Immunol 1990;144:909-915.
52. Tan LJ, Kennedy MK, Dal Canto MC, Miller SD. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance. J Immunol 1991;147:1797-1802.
53. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995;182:75-85.
54. Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995;268:1185-1188.
55. Khoruts A, Miller SD, Jenkins MK. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J Immunol 1995;155:5011-5017.
56. Solimena M, De Camilli P. From Th1 to Th2: diabetes immunotherapy shifts gears. Nat Med 1996;2:1311-1312.
57. Swain SL. Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1994;1:543-552.
58. Murphy E, et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med 1996;183:901-913.
59. Ehlers S, Smith KA. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med 1991;173:25-36.